CDNA
CareDx, Inc.
Stock
$67.15+0.92 (+1.39%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $94M | $42M | $38M | −$18M | −$25M | −$19M | $33M | −$2.8M | −$4.0M | −$14M | −$17M | −$9.8M | −$3.4M | −$546K | −$1.8M |
| Capital expenditures | — | — | — | — | — | — | — | — | $2.0M | $186K | $549K | $1.2M | $733K | $98K | $141K |
| Free cash flow | — | — | — | — | — | — | — | — | −$6.0M | −$14M | −$17M | −$11M | −$4.1M | −$644K | −$1.9M |
| Stock-based compensation | $37M | $35M | $66M | $49M | $47M | $36M | $23M | $22M | $7.1M | $1.7M | $2.0M | $1.3M | $535K | $72K | $69K |
| Buybacks | — | $88M | $522K | $28M | $642K | $0 | $0 | — | — | — | — | — | — | — | — |
| Free cash flow margin | — | — | — | — | — | — | — | — | −7.9% | −30.0% | −42.0% | −38.9% | −15.0% | −2.9% | −9.4% |